Trials / Not Yet Recruiting
Not Yet RecruitingNCT05917821
New Antigens Against Glioblastoma
Identification of New Antigens Against Glioblastoma
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
In this study the investigators will select and develop potential therapeutic monoclonal antibodies (mAbs) for glioblastoma (GB). Activities include tissue microarray (TMA) to test monoclonal antibodies specificity and target distribution, selection of glioblastoma specific functional monoclonal antibodies, identification of candidate targets.
Conditions
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2027-07-30
- Completion
- 2027-09-30
- First posted
- 2023-06-26
- Last updated
- 2023-07-24
Source: ClinicalTrials.gov record NCT05917821. Inclusion in this directory is not an endorsement.